Table 2.
Variable | Total (N = 1286) | BZRA use (N = 217) | No BZRA use (N = 1069) | p valuea |
---|---|---|---|---|
n (%) | n (%) | n (%) | ||
Age | 0.004 | |||
65–74 years | 732 (56.9) | 102 (47.0) | 630 (58.9) | |
75–84 years | 439 (34.1) | 89 (41.0) | 350 (32.7) | |
85 years or more | 115 (8.9) | 26 (12.0) | 89 (8.3) | |
Gender | <0.001 | |||
Female | 683 (53.1) | 138 (63.6) | 545 (51.0) | |
Household income | <0.001 | |||
Quintile 1 (lowest quintile) | 192 (14.9) | 28 (12.9) | 164 (15.3) | |
Quintile 2 | 307 (23.9) | 61 (28.1) | 246 (23.0) | |
Quintile 3 | 248 (19.3) | 55 (25.3) | 193 (18.1) | |
Quintile 4 | 203 (15.8) | 30 (13.8) | 173 (16.2) | |
Quintile 5 (highest quintile) | 195 (15.2) | 21 (9.7) | 174 (16.3) | |
Missing data | 141 (11.0) | 22 (10.1) | 119 (11.1) | |
Reporting an anxiety disorder | <0.001 | |||
Yes | 111 (8.6) | 34 (15.7) | 77 (7.2) | |
Reporting a sleeping disorder | <0.001 | |||
Yes | 390 (30.3) | 105 (48.4) | 285 (26.7) | |
Mean score of positive mental health | <0.001 | |||
⩾50 | 862 (67.0) | 107 (49.3) | 755 (70.6) | |
<50 | 261 (19.6) | 82 (36.9) | 179 (16.1) | |
Missing | 163 (12.7) | 28 (12.9) | 135 (12.6) | |
EQ-5D-5L score, median (P25;P75)b | 0.76 [0.64; 1.00] | 0.66 [0.49; 0.76] | 0.77 [0.68; 1.00] | <0.001 |
Mean number of chronic conditionsc | <0.001 | |||
0–1 | 590 (45.9) | 66 (30.4) | 524 (49.0) | |
2–5 | 614 (47.7) | 125 (57.6) | 489 (45.7) | |
6 or more | 77 (6.0) | 25 (11.5) | 52 (4.8) | |
Fall in the past 12 months | <0.001 | |||
Yes | 226 (17.6) | 66 (30.4) | 160 (15.0) | |
Number of medications excluding BZRA | <0.001 | |||
0–4 | 942 (73.3) | 109 (50.2) | 833 (77.9) | |
5–9 | 302 (23.5) | 90 (41.5) | 212 (19.8) | |
10 or more | 42 (3.3) | 18 (4.6) | 24 (2.2) | |
Number of contacts with GP in the past 12 months | <0.001 | |||
0 | 449 (34.9) | 36 (16.6) | 413 (38.6) | |
1 | 527 (41.0) | 91 (41.9) | 436 (40.8) | |
⩾2 | 310 (24.1) | 90 (41.5) | 220 (18.7) |
Comparison BZRA use versus No BZRA use: Pearson’s chi-squared test, Fisher’s exact test or Mann–Whitney test.
52 missing values (n = 52/1286, 4%).
5 missing values (n = 5/1286; 0.4%).
BZRA, benzodiazepine receptor agonists (ATC N05BA, N05CD, and N05CF); EQ-5D-5L, EuroQol 5 dimensions, 5 levels.